王 琪,胡伟国,宋启斌.放射性纤维化的临床干预现状及靶向治疗前景[J].中国肿瘤,2014,23(9):765-769.
放射性纤维化的临床干预现状及靶向治疗前景
Current Status of Clinical Intervention and Targeted Therapy for Radiation Fibrosis
投稿时间:2014-02-19  
DOI:10.11735/j.issn.1004-0242.2014.09.A013
中文关键词:  放射性纤维化  分子靶向治疗  转化生长因子  酪氨酸激酶抑制剂
英文关键词:radiation fibrosis  molecular targeted therapy  TGF  tyrosine kinase inhibitor
基金项目:
作者单位
王 琪 武汉大学人民医院 
胡伟国 武汉大学人民医院 
宋启斌 武汉大学人民医院 
摘要点击次数: 1884
全文下载次数: 855
中文摘要:
      摘 要:放射性纤维化是放射性损伤的重要组成部分,而目前临床中仍缺乏有效方法预防治疗放射性纤维化。现有的干预放射性纤维化的方法包括抗炎治疗、高压氧疗、抗氧化治疗,已有临床资料证实其有效性,但仍需大型随机对照试验的进一步证实。随着人们对放射性纤维化病理过程的认识,许多潜在的治疗靶点被发现,包括TGFβ1、CTGF、酪氨酸激酶抑制剂。全文对放射性纤维化的临床现状及可选择的治疗靶点进行系统综述。
英文摘要:
      Abstract:Radiation fibrosis is an important component of radiation injury,and the current clinical treatment still lacks effective methods to prevent radiation fibrosis. Clinical therapeutic interventions for radiation fibrosis includs:anti-inflammatory treatment,hyperbaric oxygen therapy and antioxidant treatment. Although some clinical trials have provided effective evidence for therapeutic efficacy,but it remains to be confirmed in large randomized controlled trials. As people’s awareness of radiation fibrosis pathological process,many potential therapeutic targets are found,including:TGFβ1,CTGF,tyrosine kinase inhibitors. Clinical status and therapeutic target for radiation fibrosis are systematic reviewed in this paper.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器